Applications of Liquid Radiochromatography Techniques in Drug Metabolism Studies

Drug Metabolism in Drug Design and Development: Basic Concepts and Practice

Volumn , Issue , 2007, Pages 287-317

  Zhu, Mingshe ^a   Zhao, Weiping ^a   Humphreys, W Griffith ^a  

^a BRISTOL MYERS SQUIBB   (United States)

Author keywords

Liquid radiochromatographic techniques; Metabolite structural characterization; Off line liquid radiochromatographic detection technique

Indexed keywords

EID: 84889482584     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470191699.ch10     Document Type: Chapter

References (58)

1. Boernsen KO, Floeckher JM, Bruin GJ. Use of a microplate scintillation counter as a radioactivity detector for miniaturized separation techniques in drug metabolism. Anal Chem 2000;72:3956-3959.
2. Brown K, Dingley KH, Turteltaub KW. Accelerator mass spectrometry for biomedical research. Methods Enzymol 2005;402:423-443.
3. Brown K, Tompkins EM, White IN. Applications of accelerator mass spectrometry for pharmacological and toxicological research. Mass Spectrom Rev 2006;25:127-145.
4. Bruin GJ, Waldmeier F, Boernsen KO, Pfaar U, Gross G, Zollinger M. A microplate solid scintillation counter as a radioactivity detector for high performance liquid chromatography in drug metabolism: validation and applications. J Chromatogr A 2006;1133:184-194.
5. Bu HZ, Kang P, Zhao P, Pool WF, Wu EY. A simple sequential incubation method for deconvoluting the complicated sequential metabolism of capravirine in humans. Drug Metab Dispos 2005;33:1438-1445.
6. Buchholz BA, Fultz E, Haack KW, Vogel JS, Gilman SD, Gee SJ, Hammock BD, Hui X, Wester RC, Maibach HI. HPLC-accelerator MS measurement of atrazine metabolites in human urine after dermal exposure. Anal Chem 1999;71:3519-3525.
7. Chando TJ, Everett DW, Kahle AD, Starrett AM, Vachharajani N, Shyu WC, Kripalani KJ, Barbhaiya RH. Biotransformation of irbesartan in man. Drug Metab Dispos 1998;26:408-417.
8. Dalvie D. Recent advances in the applications of radioisotopes in drug metabolism, toxicology, and pharmacokinetics. Curr Pharm Des 2000;6:1009-1028.
9. Dear GJ, Patel N, Kelly PJ, Webber L, Yung M. TopCount coupled to ultraperformance liquid chromatography for the profiling of radiolabeled drug metabolites in complex biological samples. J Chromatogr B Analyt Technol Biomed Life Sci 2006;844:96-103.
10. Egnash LA, Ramanathan R. Comparison of heterogeneous and homogeneous radioactivity flow detectors for simultaneous profiling and LC-MS/MS characterization of metabolites. J Pharm Biomed Anal 2002;27:271-284.
11. Ethell BT, Anderson GD, Beaumont K, Rance DJ, Burchell B. A universal radiochemical high-performance liquid chromatographic assay for the determination of UDP-glucuronosyltransferase activity. Anal Biochem 1998;255:142-147.
12. Evans DC, Watt AP, Nicoll-Griffith DA, Baillie TA. Drug-protein adducts: an industry perspective on minimizing the potential for drug bioactivation in drug discovery and development. Chem Res Toxicol 2004;17:3-16.
13. Everett DW, Chando TJ, Didonato GC, Singhvi SM, Pan HY, Weinstein SH. Biotransformation of pravastatin sodium in humans. Drug Metab Dispos 1991;19:740-748.
14. Fouda HG, Avery MJ, Dalvie D, Falkner FC, Melvin LS, Ronfeld RA. Disposition and metabolism of tenidap in the rat. Drug Metab Dispos 1997;25:140-148.
15. Garner RC. Accelerator mass spectrometry in pharmaceutical research and development a new ultrasensitive analytical method for isotope measurement. Curr Drug Metab 2000;1:205-213.
16. Garner RC, Goris I, Laenen AA, Vanhoutte E, Meuldermans W, Gregory S, Garner JV, Leong D, Whattam M, Calam A, Snel CA. Evaluation of accelerator mass spectrometry in a human mass balance and pharmacokinetic study-experience with 14C-labeled (R)-6-[amino(4-chlorophenyl)(1-methyl-1H-imidazol-5-yl)methyl]-4-(3-chlorophenyl)-1-methyl-2(1H)-quinolinone (R115777), a farnesyl transferase inhibitor. Drug Metab Dispos 2002;30:823-830.
17. Gedamke R, Zhao W, Gozo S, Mitroka J, Zhu M. A sensitive method for plasma metabolite identification using nano LC/ion trap MS in conjunction with a microplate scintillation counter. ASMS Archive Abstract 2003.
18. Graf BA, Mullen W, Caldwell ST, Hartley RC, Duthie GG, Lean ME, Crozier A, Edwards CA. Disposition and metabolism of [2-14C]quercetin-40-glucoside in rats. Drug Metab Dispos 2005;33:1036-1043.
19. Hazai I, Patfalusi M, Klebovich I, Urmos I. Whole-body autoradiography and quantitative organ-level distribution study of deramciclane in rats. J Pharm Pharmacol 1999;51:165-174.
20. Heath TG, Mooney JP, Broersma R. Narrow-bore liquid chromatography-tandem mass spectrometry with simultaneous radioactivity monitoring for partially characterizing the biliary metabolites of an arginine fluoroalkyl ketone analog of D-MePhe-Pro-Arg, a potent thrombin inhibitor. J Chromatogr B Biomed Sci Appl 1997;688:281-289.
21. Hyllbrant B, Tyrefors N, Markides KE, Langstrom B. On the use of liquid chromatography with radio-and ultraviolet absorbance detection coupled to mass spectrometry for improved sensitivity and selectivity in determination of specific radioactivity of radiopharmaceuticals. J Pharm Biomed Anal 1999;20:493-501.
22. Hett KF, Ethell BT, Maggs JL, Davis TM, Batty KT, Burchell B, Binh TQ, Thu le TA, Hung NC, Pirmohamed M, Park BK, Edwards G. Glucuronidation of dihydroartemisinin in vivo and by human liver microsomes and expressed UDP-glucuronosyltransferases. Drug Metab Dispos 2002;30:1005-1012.
23. Johnson KA, Plumb R. Investigating the human metabolism of acetaminophen using UPLC and exact mass oa-TOF MS. J Pharm Biomed Anal 2005;39:805-810.
24. Kiffe M, Jehle A, Ruembeli R. Combination of high-performance liquid chromatography and microplate scintillation counting for crop and animal metabolism studies: a comparison with classical on-line and thin-layer chromatography radioactivity detection. Anal Chem 2003;75:723-730.
25. Lautala P, Ulmanen I, Taskinen J. Radiochemical high-performance liquid chromatographic assay for the determination of catechol O-methyltransferase activity towards various substrates. J Chromatogr B Biomed Sci Appl 1999;736:143-151.
26. Lee DY. A novel dynamic flow system for sensitive radioactivity detection in LC/MS. Drug Metab Rev 2006;38 (Suppl 2):33.
27. Li W, Zhang D, Wang L, Zhang H, Cheng PT, Everett DW, Humphreys WG. Biotransformation of carbon-14-labeled muraglitazar in male mice: interspecies difference in metabolic pathways leading to unique metabolites. Drug Metab Dispos 2006;34:807-820.
28. Liberman RG, Tannenbaum SR, Hughey BJ, Shefer RE, Klinkowstein RE, Prakash C, Harriman SP, Skipper PL. An interface for direct analysis of 14-C in nonvolatile samples by accelerator mass spectrometry. Anal Chem 2004;76:328-334.
29. Magyar K, Lengyel J, Klebovich I, Urmos I, Grezal G. Distribution of deramciclane (EGIS-3886) in rat brain regions. Eur J Drug Metab Pharmacokinet 1998;23:125-131.
30. Marathe PH, Shyu WC, Humphreys WG. The use of radiolabeled compounds for ADME studies in discovery and exploratory development. Curr Pharm Des 2004;10:2991-3008.
31. Meneses-Lorente G, Sakatis MZ, Schulz-Utermoehl T, DeNardi C, Watt AP. A quantitative high-throughput trapping assay as a measurement of potential for bioactivation. Anal Biochem 2006;351:266-272.
32. Morovjan G, Dalmadi-Kiss B, Klebovich I, Mincsovics E. Metabolite analysis, isolation, and purity assessment using various liquid chromatographic techniques combined with radioactivity detection. J Chromatogr Sci 2002;40:603-608.
33. Mullen W, Graf BA, Caldwell ST, Hartley RC, Duthie GG, Edwards CA, Lean ME, Crozier A. Determination of flavonol metabolites in plasma and tissues of rats by HPLC-radiocounting and tandem mass spectrometry following oral ingestion of [2-(14)C]quercetin-40-glucoside. J Agric Food Chem 2002;50:6902-6909.
34. Mullen W, Hartley RC, Crozier A. Detection and identification of 14C-labeled flavonol metabolites by high-performance liquid chromatography-radiocounting and tandem mass spectrometry. J Chromatogr A 2003;1007:21-29.
35. Nassar AE, Bjorge SM, Lee DY. On-line liquid chromatography-accurate radioisotope counting coupled with a radioactivity detector and mass spectrometer for metabolite identification in drug discovery and development. Anal Chem 2003;75:785-790.
36. Nassar AE, Parmentier Y, Martinet M, Lee DY. Liquid chromatography-accurate radioisotope counting and microplate scintillation counter technologies in drug metabolism-studies. J Chromatogr Sci 2004;42:348-353.
37. Nedderman AN, Savage ME, White KL, Walker DK. The use of 96-well Scintiplates to facilitate definitive metabolism studies for drug candidates. J Pharm Biomed Anal 2004;34:607-617.
38. Staack RF and Hopfgarner G. New analytical strategies in drug metabolism. Anal Bioanal Chem 2007;388:1365-1380.
39. Thompson DC, Perera K, London R. Quinone methide formation from para isomers of methylphenol (cresol), ethylphenol, and isopropylphenol: relationship to toxicity. Chem Res Toxicol 1995;8:55-60.
40. Veltkamp AC. Radiochromatography in pharmaceutical and biomedical analysis. J Chromatogr 1990;531:101-129.
41. Vlasakova V, Brezinova A, Holik J. Study of cytokinin metabolism using HPLC with radioisotope detection. J Pharm Biomed Anal 1998;17:39-44.
42. Wallace D, Hildesheim A, Pinto LA. Comparison of benchtop microplate beta counters with the traditional gamma counting method for measurement of chromium-51 release in cytotoxic assays. Clin Diagn Lab Immunol 2004;11:255-260.
43. Wang G, Hsieh Y, Cui X, Cheng KC, Korfmacher WA. Ultra-performance liquid chromatography/tandem mass spectrometric determination of testosterone and its metabolites in in vitro samples. Rapid Commun Mass Spectrom 2006a;20:2215-2221.
44. Wang J, Zhao X, Zheng Y, Kong H, Lu G, Cai Z, Xu G. Metabolite fingerprint and biomarkers identification of rat urine after dosed with ginsenoside Rg3 based on ultra high performance liquid chromatography/time-of-flight mass spectrometry (UPLC/TOF-MS)]. Se Pu 2006b;24:5-9.
45. White IN, Brown K. Techniques: the application of accelerator mass spectrometry to pharmacology and toxicology. Trends Pharmacol Sci 2004;25:442-447.
46. Zhang D, Krishna R, Wang L, Zeng J, Mitroka J, Dai R, Narasimhan N, Reeves RA, Srinivas NR, Klunk LJ. Metabolism, pharmacokinetics, and protein covalent binding of radiolabeled MaxiPost (BMS-204352) in humans. Drug Metab Dispos 2005;33:83-93.
47. Zhang D, Ogan M, Gedamke R, Roongta V, Dai R, Zhu M, Rinehart JK, Klunk L, Mitroka J. Protein covalent binding of maxipost through a cytochrome P450-mediated orthoquinone methide intermediate in rats. Drug Metab Dispos 2003;31:837-845.
48. Zhang D, Wang L, Chandrasena G, Ma L, Zhu M, Zhang H, Davis CD, Humphreys WG. Involvement of multiple cytochrome P450 and UDP-glucuronosyltransferase enzymes in the in vitro metabolism of muraglitazar. Drug Metab Dispos 2007a;35:139-149.
49. Zhang D, Wang L, Raghavan N, Zhang H, Li W, Cheng PT, Yao M, Zhang L, Zhu M, Bonacorsi S, Yeola S, Mitroka J, Hariharan N, Hosagrahara V, Chandrasena G, Shyu WC, Humphreys WG. Comparative metabolism of radiolabeled muraglitazar in animals and humans by quantitative and qualitative metabolite profiling. Drug Metab Dispos 2007b;35:150-167.
50. Zhang D, Zhao W, Roongta VA, Mitroka JG, Klunk LJ, Zhu M. Amide N-glucuronidation of MaxiPost catalyzed by UDP-glucuronosyltransferase 2B7 in humans. Drug Metab Dispos 2004;32:545-551.
51. Zhao W, Wang L, Zhang D, Zhu M. Rapid and sensitive determination of enzyme kinetics of drug metabolism using HPLC coupled with a stop-flow radioactivity flow detector. Drug Metab Rev 2004;36:257.
52. Zhao W, Zhang H, ZH, Zhu M, Warrack B, Ma L, Humphreys WG, Sanders M. An integrated method for quantification and identification of radiolabeled metabolites:application of chip-based nanoelectrospray and mass defect filter techniques. ASMS Archive Abstract.
53. Zhu M, Ma L, Zhang D, Ray K, Zhao W, Humphreys WG, Skiles G, Sanders M, Zhang H. Detection and characterization of metabolites in biological matrices using Mass defect filtering of liquid chromatography/High resolution mass spectrometry data. Drug Metab Dispos. 2006;34:1722-1733.
54. Zhu M, Wang L, Gedamke R, Zhao W, Zhang D, Gozo S. Determination of radioactivity distribution and metabolite profiles in tissues using a combination of microplate scintillation counting, capillary LC/MS and whole-body autoradiography. Drug Metab Rev 2003;35:76.
55. Zhu M, Zhang H, Zhao W, Mitroka J, Klunk L. A novel in vitro approach, using a microplate scintillation counter and LC/MS, for determining formation pathways and structures of sequential metabolites: Buspirone as an example. Drug Metab Rev 2002;34:167.
56. Zhu M, Zhao W, Jimenez H, Zhang D, Yeola S, Dai R, Vachharajani N, Mitroka J. Cytochrome P450 3A-mediated metabolism of buspirone in human liver microsomes. Drug Metab Dispos 2005a;33:500-507.
57. Zhu M, Zhao W, Vazquez N, Mitroka JG. Analysis of low level radioactive metabolites in biological fluids using high-performance liquid chromatography with microplate scintillation counting: method validation and application. J Pharm Biomed Anal 2005b;39:233-245.
58. Zhu M, Zhang D, Skills G. Quantification and structural elucidation of low quantities for radiolabeled metabolites using microplate scintillation counting (MSC) techniques in conjunction with LC/MS. In: Chowdhurry SK, editor. Identification and quantification of Drugs, Metabolites and Metabolizing Enzymes. Amsterdam:Elsevier; 2005c. p 195-223.